Valérie Vial

561 total citations
14 papers, 332 citations indexed

About

Valérie Vial is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Valérie Vial has authored 14 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Valérie Vial's work include Renal cell carcinoma treatment (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Glioma Diagnosis and Treatment (2 papers). Valérie Vial is often cited by papers focused on Renal cell carcinoma treatment (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Glioma Diagnosis and Treatment (2 papers). Valérie Vial collaborates with scholars based in France, Monaco and United States. Valérie Vial's co-authors include Jérôme Durivault, Jacques Pouysségur, Milica Vučetić, Sandy Giuliano, Scott K. Parks, Yann Cormerais, Michael F. Wempe, Éric Tambutté, Hitoshi Endou and Gilles Pagès and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Theranostics.

In The Last Decade

Valérie Vial

14 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Valérie Vial France	8	205	147	68	61	46	14	332
Jingtao Luo China	9	227 1.1×	184 1.3×	66 1.0×	40 0.7×	48 1.0×	16	341
Lutfi Alfarsi United Kingdom	13	308 1.5×	237 1.6×	98 1.4×	75 1.2×	88 1.9×	19	440
Tanesha Naiken France	4	281 1.4×	215 1.5×	67 1.0×	30 0.5×	24 0.5×	5	383
Nicla Lorito Italy	9	199 1.0×	193 1.3×	71 1.0×	36 0.6×	87 1.9×	11	347
Kristina Diepold Germany	6	267 1.3×	222 1.5×	67 1.0×	19 0.3×	30 0.7×	6	404
Xiaolei Shi United States	6	412 2.0×	272 1.9×	72 1.1×	38 0.6×	40 0.9×	8	549
Brendah K. Masisi United Kingdom	9	229 1.1×	181 1.2×	69 1.0×	48 0.8×	68 1.5×	12	324
Shilpy Joshi United States	8	291 1.4×	136 0.9×	55 0.8×	21 0.3×	63 1.4×	13	415
Kristell Oizel France	7	218 1.1×	175 1.2×	52 0.8×	23 0.4×	16 0.3×	7	345
Huiming Cheng United States	5	486 2.4×	133 0.9×	118 1.7×	33 0.5×	58 1.3×	7	610

Countries citing papers authored by Valérie Vial

Since Specialization

Citations

This map shows the geographic impact of Valérie Vial's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valérie Vial with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valérie Vial more than expected).

Fields of papers citing papers by Valérie Vial

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valérie Vial. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valérie Vial. The network helps show where Valérie Vial may publish in the future.

Co-authorship network of co-authors of Valérie Vial

This figure shows the co-authorship network connecting the top 25 collaborators of Valérie Vial. A scholar is included among the top collaborators of Valérie Vial based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valérie Vial. Valérie Vial is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Sahu, Umakant, Julien Parola, Valérie Vial, et al.. (2025). De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma. Cancer Research. 85(10). 1857–1873. 1 indexed citations

Durivault, Jérôme, Valérie Vial, Rémy Villeneuve, et al.. (2024). Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via Ferroptosis. Current Oncology. 31(11). 7390–7402. 2 indexed citations

Durivault, Jérôme, Valérie Vial, Alexis Broisat, et al.. (2023). Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance. Cancer Research Communications. 3(12). 2483–2496. 5 indexed citations

Montemagno, Christopher, Jérôme Durivault, Maeva Dufies, et al.. (2023). A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma. Molecular Oncology. 17(7). 1379–1401. 5 indexed citations

Pons, Catherine, Valérie Vial, Julien Fassy, et al.. (2022). Telomerase is required for glomerular renewal in kidneys of adult mice. npj Regenerative Medicine. 7(1). 15–15. 7 indexed citations

Picco, Vincent, Valérie Vial, Vı́ctor Planas-Bielsa, et al.. (2021). Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma. Cancers. 14(1). 70–70. 13 indexed citations

Montemagno, Christopher, Benjamín Serrano, Jérôme Durivault, et al.. (2021). In vivo monitoring of the therapeutic efficacy of a CXCR1/2 inhibitor with 18F-FDG PET/CT imaging in experimental head and neck carcinoma: A feasibility study. Biochemistry and Biophysics Reports. 27. 101098–101098. 2 indexed citations

Brachet, Etienne, Jérôme Durivault, Valérie Vial, et al.. (2021). Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma. Journal of Experimental & Clinical Cancer Research. 40(1). 33–33. 15 indexed citations

Montemagno, Christopher, et al.. (2021). Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas. Cells. 10(5). 1222–1222. 12 indexed citations

10.

Giuliano, Sandy, Maeva Dufies, Papa Diogop Ndiaye, et al.. (2019). Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5. Theranostics. 9(4). 1181–1199. 24 indexed citations

11.

Parks, Scott K., Valérie Vial, Jérôme Durivault, et al.. (2018). AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity. BMC Cancer. 18(1). 249–249. 11 indexed citations

12.

Cormerais, Yann, Milica Vučetić, Sandy Giuliano, et al.. (2018). The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5). Journal of Biological Chemistry. 293(8). 2877–2887. 137 indexed citations

13.

Vučetić, Milica, Jérôme Durivault, Valérie Vial, et al.. (2017). Disrupting glucose-6-phosphate isomerase fully suppresses the “Warburg effect” and activates OXPHOS with minimal impact on tumor growth except in hypoxia. Oncotarget. 8(50). 87623–87637. 74 indexed citations

14.

Pouchelon, J.‐L., et al.. (1997). Diagnosis of pulmonary thromboembolism in a cat using echocardiography and pulmonary scintigraphy. Journal of Small Animal Practice. 38(7). 306–310. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact